Authors: Amardeep Udeshi, SVP, EVERSANA APAC; Ankit Kulshrestha, Senior Principal, EVERSANA APAC; Nishit Patadia, Engagement Manager, EVERSANA APAC
In the dynamic landscape of the pharmaceutical industry, traditional linear market access approaches are no longer sufficient. This paper explores the innovative strategies that pharmaceutical companies can adopt to navigate the complexities of emerging markets. Key highlights include:
- Holistic Market Access: Integrating commercial, regulatory, supply chain, marketing, and medical functions to ensure timely and affordable patient access.
- Second Brands: Leveraging second brands to enhance market penetration, manage product life cycles, and protect brand equity.
- Case Studies: Real-world examples, such as Roche’s dual-brand strategy in Egypt, demonstrate the effectiveness of tailored pricing and distribution strategies.
Discover how adopting a modern, multifaceted approach can help pharmaceutical companies overcome market challenges and achieve sustained success. Complete the form to download the full paper.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…